Skip to main content
Fig. 10 | Journal of Neuroinflammation

Fig. 10

From: Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway

Fig. 10

Effects of Nrf2 siRNA and Nrf2 siRNA with ILG co-treatment on the protein levels of NF-κB p65 and NLRP3 inflammasome pathway components after ICH. WB assay (a) and quantification of NF-κB p65 (b), NLRP3 (c), ASC (d), caspase-1 (e), and IL-1β (f) protein levels after Nrf2 siRNA and ILG 20 mg/kg co-treatment at 24 h following ICH (n = 6 rats/group). Data are indicated by means ± SD. **p < 0.01; *p < 0.05

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094